Mobile Insulin Titration Intervention (MITI)
The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes
Sponsor: NYU Langone Health
A NA clinical study on Diabetes Mellitus, this trial is completed. The trial is conducted by NYU Langone Health and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Jun 2019 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
- New York City Health and Hospitals Corporation
For direct contact, visit the study record on ClinicalTrials.gov .